Skip to application
All calculators and tools

Preparation. Administration. Evidence.

IV Dilution &
Medication Reference

Search 255 medications, read preserved historical references, and inspect separately reviewed preparation statements. Full monograph updates remain pending.

Version 6.4Release date 2026-11-04For healthcare professionals
Back to resultsA-Z list

Medication reference

Amphotericin B lipid complex (Abelcet)

Monograph awaiting updateThis monograph will be updated in the future.

Jump to a section

Historical source. Current clinical review is incomplete. This monograph will be updated in the future.

Ampho B Lipid Complex (abelcet®) (opens in a new tab)Original source URL: https://globalrph.com/dilution/amphotericin-b-lipid-complex-abelcet/ | Retrieved 2026-11-04

Source dates, location and integrity

This historical article is separate from the reviewed claim cards. Product formulations and source dates may differ.

Original source URL
https://globalrph.com/dilution/amphotericin-b-lipid-complex-abelcet/ (opens in a new tab)
Source date
Not established in the retrieved source
Retrieved
2026-11-04T19:45:54.165308+00:00
Source location
div.post-content
Packaged content SHA-256
7d7c16558146d29b3ea1c2bba29bc488a807864879435a927318ab339a16e9d5
Original response SHA-256
f30cccd4608809fd975becbc03960854c64883fc9bf264ccd9298a2d6990cd70
Source body SHA-256
46a411c9ffd74976135e900489d1a9b11ce3333b266208c58d1038907c423673

AMPHOTERICIN B LIPID COMPLEX (ABELCET ®)

The authors make no claims of the accuracy of the information contained herein; and these suggested doses and/or guidelines are not a substitute for clinical judgment. Neither GlobalRPh Inc. nor any other party involved in the preparation of this document shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user's use of or reliance upon this material. PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER.

Usual Diluents

D5W

Standard Dilutions [Amount of drug] [Infusion volume] [Infusion rate]

---Concentration 1 mg/ml---
[300 mg/ 240 ml] [2 hours]
[350 mg/280 ml] [2 hours]
[400 mg/ 320 ml] [2 hours]

Minimum dilution:
[300mg/ 90ml] [2 hours]

Stability / Miscellaneous

Indications: treatment of aspergillosis in patients who are refractory to or intolerant of conventional ampho-B therapy.

DOSAGE AND ADMINISTRATION
The recommended daily dosage for adults and children is 5 mg/kg given as a single infusion. ABELCET® should be administered by intravenous infusion at a rate of 2.5 mg/kg/h. If the infusion time exceeds 2 hours, mix the contents by shaking the infusion bag every 2 hours.

Renal toxicity of ABELCET®, as measured by serum creatinine levels, has been shown to be dose dependent. Decisions about dose adjustments should be made only after taking into account the overall clinical condition of the patient.

Preparation of Admixture for Infusion
Shake the vial gently until there is no evidence of any yellow sediment at the bottom. Withdraw the appropriate dose of ABELCET® from the required number of vials into one or more sterile 20 mL syringes using an 18-gauge needle. Remove the needle from each syringe filled with ABELCET® and replace with the 5-micron filter needle supplied with each vial. Each filter needle may be used to filter the contents of up to four vials. Insert the filter needle of the syringe into an IV bag containing 5% Dextrose Injection USP, and empty the contents of the syringe into the bag. The final infusion concentration should be 1 mg/mL. For pediatric patients and patients with cardiovascular disease the drug may be diluted with 5% Dextrose Injection to a final infusion concentration of 2 mg/mL. Before infusion, shake the bag until the contents are thoroughly mixed. Do not use the admixture after dilution with 5% Dextrose Injection if there is any evidence of foreign matter. Vials are for single use. Unused material should be discarded. Aseptic technique must be strictly observed throughout handling of ABELCET®, since no bacteriostatic agent or preservative is present.

DO NOT DILUTE WITH SALINE SOLUTIONS OR MIX WITH OTHER DRUGS OR ELECTROLYTES as the compatibility of ABELCET® with these materials has not been established. An existing intravenous line should be flushed with 5% Dextrose Injection before infusion of ABELCET®, or a separate infusion line should be used. DO NOT USE AN IN-LINE FILTER.

Stability:
The diluted ready-for-use admixture is stable for up to 48 hours at 2° to 8°C (36° to 46°F) and an additional 6 hours at room temperature.

HOW SUPPLIED
Each vial contains 100 mg of ABELCET® in 20 mL of suspension. Single-use vials along with 5-micron filter needles are individually packaged. NDC 61799-101-41.

STORAGE
Prior to admixture, ABELCET® should be stored at 2° to 8°C (36° to 46°F) and protected from exposure to light. Do not freeze. ABELCET® should be retained in the carton until time of use.

The admixed ABELCET® and 5% Dextrose Injection may be stored for up to 48 hours at 2° to 8°C (36° to 46°F) and an additional 6 hours at room temperature. Do not freeze. Any unused material should be discarded.

Open this historical article on its own

Product identifiers and clinical review status

This monograph will be updated in the future. Historical material is available where present in the original sources; full current exact-product and claim-level review remains pending.

Exact formulation, concentration, container, manufacturer, regulatory identifiers, and a reproducible label snapshot have not all been reconciled.

What remains to be completed
  • Retrievable exact-product SPL XML with version, revision, retrieval date and reproducible hash
  • Clinically reviewed, individually identified statements with two exact source mappings
  • Exact formulation, strength, container, manufacturer/labeler, application and NDC reconciliation
  • Renal-function methods and dialysis/CRRT modality review where applicable
  • Mechanism provenance, clinical source disagreements and full medication-specific safety reconciliation

Supplemental historical fields

Restored-data provenance and review notes

Source release: 2026-08-31. Current clinical review is incomplete. Original uses of current, verified, or normalized describe the historical source. They do not inherit the status of separately reviewed statements. Product formulations and source dates can differ.

Current review annotations for historical renal, dialysis, mechanism, and product fieldsSeparate renal reference: Open Renal Dosing Master (opens in a new tab)
Renal
Status
not_locally_normalized
Original classification
monitor_or_titrate
Entries
    General note
    Preserve the source-specific renal-function basis. An indexed CrCl table is not interchangeable with unindexed CrCl or eGFR. Generic advice to check a method does not identify the equation for a dose row.
    Dialysis
    Status
    no_local_structured_regimen
    Entries
      General note
      Named modality alone does not establish applicability. CRRT subtype, effluent rate, residual renal function, timing and interruptions require review. Historical absence is not evidence that no guidance exists.
      Mechanisms
      • Source kind
        first_look
        Local pointer
        /mechanism
        Original level
        drug_specific
        Provenance classification
        historical_drug_specific_uncorroborated
        Label derived verified
        false
        Independently corroborated
        false
        Exact label section
        Not recorded
        Original source note
        Not recorded
        Review status
        historical_unverified
        Note
        Drug-specific wording in the old file is not proof of independent corroboration or an exact label locator. Consult separately published current mechanism claims where present.
      • Source kind
        label_snapshot
        Local pointer
        /mechanism_summary
        Original level
        drug_specific
        Provenance classification
        historical_drug_specific_uncorroborated
        Label derived verified
        false
        Independently corroborated
        false
        Exact label section
        Not recorded
        Original source note
        GlobalRPh drug-specific mechanism summary retained alongside the selected DailyMed label.
        Review status
        historical_unverified
        Note
        Drug-specific wording in the old file is not proof of independent corroboration or an exact label locator. Consult separately published current mechanism claims where present.
      Future update
      Status
      pending_review
      Message
      This monograph will be updated in the future as current exact-product and claim-level review is completed.
      Source unavailable
      false
      Reason
      The historical content is restored; comprehensive contemporary verification remains incomplete.
      Historical first look: uses, mechanism, dosing context, and administration

      Recovered v5.1 source content; historical, awaiting current review.

      Id
      amphotericin-b-lipid-complex-abelcet
      Source IDH51-EC12E0680A64DB8540BDCAC9
      Generic name
      Amphotericin B lipid complex (Abelcet)
      Source IDH51-F87102A775E7537EF87C9CF2
      Class
      Antifungal
      Source IDH51-F77D1FED80912ABA84C56459
      Subclass
      Legacy GlobalRPh directory entry
      Source IDH51-9919CC0EA6063D1DAE087B3F
      Primary uses
      1. Severe or invasive fungal infection when the organism, site, patient factors, and current labeling support IV therapy.
        Source IDH51-6857F1B01FEA9C9CEA158A72
      Mechanism
      Binds fungal membrane ergosterol, forms pores, and causes leakage of intracellular contents.
      Source IDH51-CE9F8A74E007CD5AF805CA2D
      Mechanism level
      drug_specific
      Source IDH51-0CC0CA1C5F1B6BE23DB83351
      Basic dosing orientation
      Adult dosing is weight based and indication specific. The labeled daily dose is weight based for adults and children. A 2 mg/mL final concentration is label supported for pediatric patients. Neonatal dosing is not generated from the adult preparation summary.
      Source IDH51-9847926636C3185EA09D4323
      Administration orientation
      Infuse at the label-specified rate, commonly 2.5 mg/kg/hour. Do not administer as IV push. Withdraw through the supplied 5-micron filter needle; each filter needle may filter up to four 100 mg vials. Flush an existing line with D5W or use a separate line. Do not use an in-line filter during infusion.
      Source IDH51-D97CA7E125DFB6319EF3FB34
      Renal and population orientation
      Separate renal reference: Open Renal Dosing Master (opens in a new tab)Renal function materially affects toxicity, monitoring, or titration even when a fixed table may not apply.
      Source IDH51-8E4DF0E688EB36684E6A0BF5
      Key safety orientation
      1. Archived-label status: confirm current U.S. product availability before use. Verify Abelcet versus AmBisome versus conventional amphotericin B before preparing the dose; these formulations are not interchangeable.
        Source IDH51-EA2F8ACB7000E281FFD4B611
      2. Legacy content must be reconciled against current labeling and institutional policy before clinical use.
        Source IDH51-CFBA4FD877830AD2C31B7C43
      Coverage path
      reviewed_local_label_summary
      Source IDH51-83A235DA6F1B55D1CCD1E06B
      Coverage path label
      Reviewed local package-insert summary
      Source IDH51-DBB217CD959407724F005DDB
      Legacy title
      Amphotericin B lipid complex (Abelcet)
      Source IDH51-6111A58C3594140A080CA215
      Review note
      First-look orientation only. Verify indication, patient population, weight basis, organ function, exact IV product, dose, concentration, compatibility, rate, and current labeling before use.
      Source IDH51-E030FCB780DDE2766ADA0144
      Search text
      Amphotericin B lipid complex (Abelcet) Antifungal Legacy GlobalRPh directory entry Severe or invasive fungal infection when the organism, site, patient factors, and current labeling support IV therapy. Binds fungal membrane ergosterol, forms pores, and causes leakage of intracellular contents. Adult dosing is weight based and indication specific. The labeled daily dose is weight based for adults and children. A 2 mg/mL final concentration is label supported for pediatric patients. Neonatal dosing is not generated from the adult preparation summary. Infuse at the label-specified rate, commonly 2.5 mg/kg/hour. Do not administer as IV push. Withdraw through the supplied 5-micron filter needle; each filter needle may filter up to four 100 mg vials. Flush an existing line with D5W or use a separate line. Do not use an in-line filter during infusion. Renal function materially affects toxicity, monitoring, or titration even when a fixed table may not apply. Archived-label status: confirm current U.S. product availability before use. Verify Abelcet versus AmBisome versus conventional amphotericin B before preparing the dose; these formulations are not interchangeable. Legacy content must be reconciled against current labeling and institutional policy before clinical use. Reviewed local package-insert summary
      Source IDH51-35992005BFC3BB6CD69FC247
      Official access mode
      direct_label
      Source IDH51-2A697EDC5813C054384B70E2
      Official access reason
      A source-specific DailyMed label route is available.
      Source IDH51-CF2EB4B0508B9BE1E00D0C35
      Label snapshot available
      true
      Source IDH51-2D87ED9E25C969EB38FC78DB
      Label snapshot setid
      5587db37-f21a-4a39-a319-e1077032ced9
      Source IDH51-380473B09C3B8F7B8E7232E0

      No separate structured rows were bundled for preparation, IV push, continuous infusion, population dosing, dialysis, CRRT. Historical article content and source links may cover these topics.

      Historical local label preparation summary

      Recovered v5.1 source content; historical, awaiting current review.

      Id
      abelcet
      Source IDH51-90248A6292A9AD095EA243D7
      Match names
      1. Amphotericin B lipid complex
        Source IDH51-5CA2B43CB1C41358095CF7D5
      2. Abelcet
        Source IDH51-58CEA27E588461D820CB9A0F
      Label title
      Amphotericin B lipid complex injection (Abelcet)
      Source IDH51-3BC888FB031D391F5CAB4677
      Brand names
      1. Abelcet
        Source IDH51-BB6F56BD85BF29A8873E7943
      Formulation
      Ready-to-dilute lipid-complex suspension, commonly 5 mg/mL in a 20 mL vial (100 mg).
      Source IDH51-12677563805B9A097FB88260
      Reconstitution
      No powder reconstitution is required. Gently mix the suspension and withdraw using the product-specified filtration or withdrawal procedure.
      Source IDH51-064A1D577873392903450EA6
      Stock concentration
      5 mg/mL.
      Source IDH51-733583780B706FE7C18B7D7E
      Diluents
      Dilute in 5% dextrose injection. Do not dilute with saline or mix with other drugs.
      Source IDH51-7001AA978E7CB27B30015602
      Final concentration
      1 mg/mL is the usual labeled final concentration. For pediatric patients and patients with cardiovascular disease, the label permits dilution in D5W to 2 mg/mL.
      Source IDH51-399A5734521A2E98875C6DE4
      Containers
      Use a D5W container sized to produce 1 mg/mL, or 2 mg/mL only for the label-supported pediatric or cardiovascular populations.
      Source IDH51-0D1BC155561766A66CC80DC6
      Infusion time
      Infuse at the label-specified rate, commonly 2.5 mg/kg/hour. Do not administer as IV push.
      Source IDH51-69AD63C46B2E1007B4086E47
      Fluid restriction
      The label-supported 2 mg/mL alternative is limited to pediatric patients and patients with cardiovascular disease. Do not create other concentrated preparations without exact-product and institutional approval.
      Source IDH51-04FD3C1E2934902703FF2C3F
      Stability
      The diluted admixture may be stored for up to 48 hours at 2 to 8 C and then for an additional 6 hours at room temperature. Do not freeze and discard unused material.
      Source IDH51-52600D3F3B6D1673325B337B
      Line filter
      Withdraw through the supplied 5-micron filter needle; each filter needle may filter up to four 100 mg vials. Flush an existing line with D5W or use a separate line. Do not use an in-line filter during infusion.
      Source IDH51-BA22986FFAF1E62F0A4CE723
      Adult applicability
      Adult dosing is weight based and indication specific.
      Source IDH51-FB9B19480AE04DFADEB387E9
      Pediatric applicability
      The labeled daily dose is weight based for adults and children. A 2 mg/mL final concentration is label supported for pediatric patients.
      Source IDH51-46BF988569EE626256CE46F1
      Neonatal applicability
      Neonatal dosing is not generated from the adult preparation summary.
      Source IDH51-CBF4CBA0023B3E2BCF7C8A2E
      Renal dialysis
      Separate renal reference: Open Renal Dosing Master (opens in a new tab)Monitor renal function, electrolytes, liver tests, blood counts, and infusion reactions.
      Source IDH51-62FB863182723CF6C81D34AF
      Key warnings
      Archived-label status: confirm current U.S. product availability before use. Verify Abelcet versus AmBisome versus conventional amphotericin B before preparing the dose; these formulations are not interchangeable.
      Source IDH51-85DFD2094142724598601013
      Catalog id
      amphotericin-b-lipid-complex-abelcet
      Source IDH51-9999F97D41BAC263F8055E36
      Catalog name
      Amphotericin B lipid complex (Abelcet)
      Source IDH51-BCE18EE1FEF1D717F07E7038
      Review date
      2026-08-30
      Source IDH51-FDE4B5FDA5DE0553E872040D
      Source type
      Reviewed local summary derived from an archived official DailyMed label; current product availability and exact marketed formulation must be confirmed before use.
      Source IDH51-3A2D514FD790F9181F335C3C
      Official link type
      DailyMed official label
      Source IDH51-C861DAECC03A91C8F0F7030F
      Search text
      Amphotericin B lipid complex Abelcet Abelcet abelcet amphotericin-b-lipid-complex-abelcet Amphotericin B lipid complex (Abelcet) Amphotericin B lipid complex injection (Abelcet) Ready-to-dilute lipid-complex suspension, commonly 5 mg/mL in a 20 mL vial (100 mg). No powder reconstitution is required. Gently mix the suspension and withdraw using the product-specified filtration or withdrawal procedure. 5 mg/mL. Dilute in 5% dextrose injection. Do not dilute with saline or mix with other drugs. 1 mg/mL is the usual labeled final concentration. For pediatric patients and patients with cardiovascular disease, the label permits dilution in D5W to 2 mg/mL. Use a D5W container sized to produce 1 mg/mL, or 2 mg/mL only for the label-supported pediatric or cardiovascular populations. Infuse at the label-specified rate, commonly 2.5 mg/kg/hour. Do not administer as IV push. The label-supported 2 mg/mL alternative is limited to pediatric patients and patients with cardiovascular disease. Do not create other concentrated preparations without exact-product and institutional approval. The diluted admixture may be stored for up to 48 hours at 2 to 8 C and then for an additional 6 hours at room temperature. Do not freeze and discard unused material. Withdraw through the supplied 5-micron filter needle; each filter needle may filter up to four 100 mg vials. Flush an existing line with D5W or use a separate line. Do not use an in-line filter during infusion. Adult dosing is weight based and indication specific. The labeled daily dose is weight based for adults and children. A 2 mg/mL final concentration is label supported for pediatric patients. Neonatal dosing is not generated from the adult preparation summary. Monitor renal function, electrolytes, liver tests, blood counts, and infusion reactions. Archived-label status: confirm current U.S. product availability before use. Verify Abelcet versus AmBisome versus conventional amphotericin B before preparing the dose; these formulations are not interchangeable. Archived official DailyMed label. The listed NDC and NDA show a marketing end date of August 31, 2025; current U.S. commercial availability was not confirmed during the 2026-08-30 review. Reviewed local summary derived from an archived official DailyMed label; current product availability and exact marketed formulation must be confirmed before use. DailyMed official label 2026-08-30
      Source IDH51-9549858FF025276B52D34355
      Label status
      Archived official DailyMed label. The listed NDC and NDA show a marketing end date of August 31, 2025; current U.S. commercial availability was not confirmed during the 2026-08-30 review.
      Source IDH51-859C06F2F9323385339E3361
      Label status level
      archived
      Source IDH51-D80B1A520EB8A6BA425C61EF

      Historical DailyMed label snapshot

      Recovered v5.1 source content; historical, awaiting current review.

      Id
      amphotericin-b-lipid-complex-abelcet
      Source IDH51-36C7059C1CC88CAB18788E10
      Catalog name
      Amphotericin B lipid complex (Abelcet)
      Source IDH51-660FE994704DFA059782A09D
      Selection status
      accepted_high_confidence
      Source IDH51-61D6F7C0BCB55A36C469E4C7
      Confidence
      very_high
      Source IDH51-470506A5AEBDCE246A659EBB
      Match path
      existing_reviewed_summary
      Source IDH51-58D717A9C68C3956EAC9B80B
      Brand name
      Abelcet
      Source IDH51-0448C0A33BF6AA547293D990
      Label title
      Amphotericin B lipid complex injection (Abelcet)
      Source IDH51-79DB2FF48DC30868DF1917A3
      Setid
      5587db37-f21a-4a39-a319-e1077032ced9
      Source IDH51-7C3020214D2E607CD185285B
      Reviewed on
      2026-08-31
      Source IDH51-489A1744006AEC16FC6EFA70
      Route
      Intravenous; see the selected product label for exact route and administration method.
      Source IDH51-90174E98ACA033969F39EBCA
      Dosage form
      Ready-to-dilute lipid-complex suspension, commonly 5 mg/mL in a 20 mL vial (100 mg).
      Source IDH51-EEA76F086E65BB2032FE951F
      Dosage administration summary
      Separate renal reference: Open Renal Dosing Master (opens in a new tab)
      1. Adult dosing is weight based and indication specific.
        Source IDH51-9382DD1DBDBD9B8C1334ECF7
      2. The labeled daily dose is weight based for adults and children. A 2 mg/mL final concentration is label supported for pediatric patients.
        Source IDH51-1791DAF86AA1389C92C78CF6
      3. Neonatal dosing is not generated from the adult preparation summary.
        Source IDH51-CEAAAFD78166F34B1DEE5824
      4. No powder reconstitution is required. Gently mix the suspension and withdraw using the product-specified filtration or withdrawal procedure.
        Source IDH51-313971DC5B7ADE709F8CD458
      5. Infuse at the label-specified rate, commonly 2.5 mg/kg/hour. Do not administer as IV push.
        Source IDH51-CA01410A822A265D4C506B08
      6. Monitor renal function, electrolytes, liver tests, blood counts, and infusion reactions.
        Source IDH51-CFCCF441CB3DF026955FFA92
      Dosage forms strengths
      1. Ready-to-dilute lipid-complex suspension, commonly 5 mg/mL in a 20 mL vial (100 mg).
        Source IDH51-0FA49A5271C1BAEFF1775CBF
      2. 5 mg/mL.
        Source IDH51-75A1EC4458EA803B99AE544B
      Mechanism summary
      Binds fungal membrane ergosterol, forms pores, and causes leakage of intracellular contents.
      Source IDH51-275AF18A73DA1322333B0765
      Mechanism source
      GlobalRPh drug-specific mechanism summary retained alongside the selected DailyMed label.
      Source IDH51-7BF06C49AC7965299FA8338B
      Scope note
      The locally reviewed preparation summary remains the primary product-specific preparation snapshot. This broader label snapshot is concise and does not reproduce the full prescribing information.
      Source IDH51-371795E482F52C18FA20876C
      Source sections
      1. Dosage and Administration
        Source IDH51-BA8475592B9CE53FC1D566CF
      2. Dosage Forms and Strengths
        Source IDH51-A56EA815A14BD04C06A40DE8
      3. Clinical Pharmacology or Microbiology as applicable
        Source IDH51-202D5E53CD010D386570FA99
      Retrieval method
      Manual build-time review of the current DailyMed full prescribing information for the selected Set ID; no live server retrieval is required during page use.
      Source IDH51-CD26F57513702D05EDA2765C
      Label status
      archived
      Source IDH51-227E3ACC81CD541B42FD54C3
      Disclaimer
      Verify the exact formulation, strength, manufacturer, NDC, route, current label revision, patient-specific order, institutional policy, and monitoring before use.
      Source IDH51-ED7F68A86334C1347584B6B4

      Historical renal-function guidance

      Recovered v5.1 source content; historical, awaiting current review.

      Separate renal reference: Open Renal Dosing Master (opens in a new tab)
      Classification
      monitor_or_titrate
      Source IDH51-BA288D116B89668079C12C6D
      Summary
      Renal function materially affects toxicity, monitoring, or titration even when a fixed table may not apply.
      Source IDH51-541A534939A90E4CBE233840
      Method note
      Use the renal function estimate and body-size convention specified by the selected label or institutional protocol. Do not interchange Cockcroft-Gault CrCl, indexed eGFR, and de-indexed eGFR without confirming the dosing source.
      Source IDH51-3BEAFF7675A9268F076ADF30

      Historical Warnings and safeguards

      Recovered v5.1 source content; historical, awaiting current review.

      1. Legacy content must be reconciled against current labeling and institutional policy before clinical use.
        Source IDH51-8A2011802254756741ACC57E

      Historical Stability notes

      Recovered v5.1 source content; historical, awaiting current review.

      1. Legacy product stability information is not automatically equivalent to a USP <797> BUD.
        Source IDH51-2E6A75FF0E0129FA43B60885

      Historical supplemental professional sources

      Recovered v5.1 source content; historical, awaiting current review.

      LabelUrlKind
      Source IDH51-BB4512AACAC33D1B36A7488F
      UCSF adult antimicrobial dosing, non-dialysis
      Source IDH51-F470DAF97BB2C59AAE7C8027
      https://idmp.ucsf.edu/adult-antimicrobial-dosing-non-dialysis (opens in a new tab)
      Source IDH51-AB8F569DD875F4BE29575673
      Professional institutional guidance
      Source IDH51-C813C01C303F2CE8ECCDD74E
      Source IDH51-F795337BE666F79CC50853BB
      UCSF antimicrobial dosing in intermittent and continuous hemodialysis
      Source IDH51-F8D31534ABBB9D194D8D5A00
      https://idmp.ucsf.edu/antimicrobial-dosing-intermittent-continuous-hemodialysis (opens in a new tab)
      Source IDH51-554D6A9E626342DEC343E8ED
      Professional institutional guidance
      Source IDH51-A483C245D6C9DEC6E5EF2C75
      Source IDH51-0FF83EF5BE642D5FE121F928
      UCSF pediatric antimicrobial dosing
      Source IDH51-F29DF5FE91F574E3B9BC4F57
      https://idmp.ucsf.edu/pediatric-antimicrobial-dosing-benioff-childrens-hospitals (opens in a new tab)
      Source IDH51-4DF150CFD92D8FB64673B70C
      Professional institutional guidance
      Source IDH51-3A9FAF53E89187D852EDB077
      Source IDH51-ABF029FD2D271514E5ECBC8C
      UCSF neonatal antimicrobial dosing
      Source IDH51-9F236747570C431CBB2421C9
      https://idmp.ucsf.edu/neonatal-antimicrobial-dosing-benioff-childrens-hospitals (opens in a new tab)
      Source IDH51-72E559D39E403B81D08C58B8
      Professional institutional guidance
      Source IDH51-15D697BF8F688799DB68FCA3
      Other recovered source fields and original editorial metadata

      Original status words such as current, verified, or normalized describe the historical source release. They do not change the clinical review status of this release.

      Catalog source fields

      Id
      amphotericin-b-lipid-complex-abelcet
      Source IDH51-A7FB1A4E7E7C3F99809C25D8
      Legacy title
      Amphotericin B lipid complex (Abelcet)
      Source IDH51-92CF55DCCBBDE95194AD41B8
      Generic name
      Amphotericin B lipid complex (Abelcet)
      Source IDH51-A8F876D24A7E2439DF6B8409
      Class
      Antifungal
      Source IDH51-3B96CBBB60B7818E2A6B9829
      Subclass
      Legacy GlobalRPh directory entry
      Source IDH51-7ECB8B9D4F3BC65B90341C44
      Summary
      Existing GlobalRPh IV dilution monograph retained for migration into the unified reference.
      Source IDH51-F298361D1D933A1BA830A704
      Populations
      1. Population not yet normalized
        Source IDH51-E8F570B625C34AC7DBD5FC27
      Evidence tier
      Reviewed archived label summary - current availability not confirmed
      Source IDH51-82D82F4D054B6662F7E37103
      High alert
      false
      Source IDH51-21DCE240EACBDB25652CD0C5
      Hazardous
      false
      Source IDH51-AD90EE3195AA202AD810A881
      Status
      Legacy migration
      Source IDH51-10511BE5646C802F13AEF959
      Reviewed
      2026-08-30
      Source IDH51-924D01E2CAA4B9800B564CC8
      Version added
      Legacy
      Source IDH51-6FA2D0BDC3960BCC57A81275
      Sources
      LabelUrlKind
      Source IDH51-C64411F1B653FA57D67D499E
      GlobalRPh legacy IV dilution monograph
      Source IDH51-D0F03061427545360F00DB73
      legacy:auto
      Source IDH51-E1268AFE337858AF4F6072B3
      Legacy
      Source IDH51-8F6B99AA92D0810646075F39
      Clinical release verification
      Audit version
      3.4
      Source IDH51-54C140C32017397F1A5FFAB9
      Audited on
      2026-08-30
      Source IDH51-2C8AFA59064D518FB000DBB7
      Level
      amber
      Source IDH51-0E02DA1B0B662F91E25E5932
      Release gate
      trusted_professional_source_present_exact_label_unconfirmed
      Source IDH51-2DF99DD9DC3792BA2E4133FA
      Exact current label candidate
      false
      Source IDH51-7C4AAFF9F0F365877E19C60F
      Reference url count
      4
      Source IDH51-EFBBE5D46BCE0D40B1F6AFEC
      Broken reference count
      0
      Source IDH51-ACA1643304109FDB0617E861
      Point of use confirmation required
      true
      Source IDH51-1E210F495164AC40ABB75926
      Note
      Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
      Source IDH51-D3F58E3F19074A808E11413C
      Version updated
      3.8
      Source IDH51-2ABCD5B81CE7B77CD5253DC3

      Dosing source fields

      Id
      amphotericin-b-lipid-complex-abelcet
      Source IDH51-90B0768AB01DF3129F249DCB
      Generic name
      Amphotericin B lipid complex (Abelcet)
      Source IDH51-E63FEEAC5D81ED8D3EF92C78
      Coverage status
      direct_official_label_access_plus_legacy_reference
      Source IDH51-E9FAC943136742538DE3CF9A
      Package insert
      Query name
      Amphotericin B lipid complex
      Source IDH51-7C53850F5D6A9D9A54F7CA77
      Product and route must match
      true
      Source IDH51-A402DE3B3D0F807ECB72F1AB
      Live current label enabled
      false
      Source IDH51-C99A2879AC5751D9F48FB4E0
      Source priority
      Reviewed local summary when available, then a verified DailyMed label or product search when available, followed by professional references and institutional policy.
      Source IDH51-00F8270F436E92E281CD30BF
      Direct official label access enabled
      true
      Source IDH51-063246BF795D202C262106C5
      Outbound server request required
      false
      Source IDH51-A2331F5A062F402245BD9ADB
      Local summary status
      archived_reviewed_summary
      Source IDH51-9556CE018D0129933FE69B91
      Clinical review
      Locally normalized
      false
      Source IDH51-C852F87A9B9EEDA168C2DE8B
      Reviewed
      2026-08-29
      Source IDH51-DFBDD2DDB0439F82A8B0D67F
      Status
      Direct official package-insert access enabled; indication-specific local normalization pending.
      Source IDH51-170AE8C618ECE976ED18C3BA
      Clinical release verification
      Audit version
      3.4
      Source IDH51-6EC9156178F970379343490A
      Audited on
      2026-08-30
      Source IDH51-CB8306F70376F58BF1101B39
      Level
      amber
      Source IDH51-3ECF328D9587B1AC79E9C75A
      Release gate
      trusted_professional_source_present_exact_label_unconfirmed
      Source IDH51-BFD39781747ACC8425308773
      Exact current label candidate
      false
      Source IDH51-EAA8D51BA11D6CD788C561E5
      Reference url count
      4
      Source IDH51-F7C34D40C84F3DF25ED287C3
      Broken reference count
      0
      Source IDH51-FED687ABAD70FDD259E229BE
      Point of use confirmation required
      true
      Source IDH51-986936927E7B0515AC189528
      Note
      Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
      Source IDH51-02AA55024F1D33B6CA5D1762
      Historical preparation assessment

      Recovered v5.1 source content; historical, awaiting current review.

      Id
      amphotericin-b-lipid-complex-abelcet
      Source IDH51-28C966B299ECED4751EE739E
      Name
      Amphotericin B lipid complex (Abelcet)
      Source IDH51-F6E957399907A7684A73DFDB
      Therapeutic class
      Antifungal
      Source IDH51-DF30314E33922F5701AE7B5F
      Review version
      3.8
      Source IDH51-98AAE8291BF8854E3A35CDF7
      Review date
      2026-08-30
      Source IDH51-0C630DCBDBB58EA83384D948
      Release status
      reviewed_archived_label_summary_marketing_status_review_required
      Source IDH51-800E0DF2777E30356D93EAEF
      Market status
      Status
      archived_label_marketing_end_date_listed
      Source IDH51-E5E2C967DC4B8940AB0D69DE
      Basis
      Archived official DailyMed label. The listed NDC and NDA show a marketing end date of August 31, 2025; current U.S. commercial availability was not confirmed during the 2026-08-30 review.
      Source IDH51-5E7C23B2D62BFBF406FD0442
      Ten point assessment
      Exact formulation
      Ready-to-dilute lipid-complex suspension, commonly 5 mg/mL in a 20 mL vial (100 mg).
      Source IDH51-78E5B557E28CF6A2657F2B9A
      Reconstitution concentration
      No powder reconstitution is required. Gently mix the suspension and withdraw using the product-specified filtration or withdrawal procedure. 5 mg/mL.
      Source IDH51-18353ADAEE276C2A4E2A26A7
      Maximum or recommended final concentration
      1 mg/mL is the usual labeled final concentration. For pediatric patients and patients with cardiovascular disease, the label permits dilution in D5W to 2 mg/mL.
      Source IDH51-B410DAF3B6F8E46DF82BEE97
      Appropriate standardized containers
      Use a D5W container sized to produce 1 mg/mL, or 2 mg/mL only for the label-supported pediatric or cardiovascular populations.
      Source IDH51-D0D591D5F1878AE720F66AD8
      Adult dosing range
      Adult dosing is weight based and indication specific.
      Source IDH51-244168F7ABAC1877C9E604D8
      Pediatric dosing range
      The labeled daily dose is weight based for adults and children. A 2 mg/mL final concentration is label supported for pediatric patients.
      Source IDH51-447D68890C90A05B7F6A3D42
      Neonatal dosing range
      Neonatal dosing is not generated from the adult preparation summary.
      Source IDH51-329499090578E391383E8CDA
      Infusion time
      Infuse at the label-specified rate, commonly 2.5 mg/kg/hour. Do not administer as IV push.
      Source IDH51-9F1AA15BBB13BD6BD55D082D
      Fluid restriction alternatives
      The label-supported 2 mg/mL alternative is limited to pediatric patients and patients with cardiovascular disease. Do not create other concentrated preparations without exact-product and institutional approval.
      Source IDH51-4686AC7D68EFBD5DBF457953
      Current manufacturer labeling
      Setid
      5587db37-f21a-4a39-a319-e1077032ced9
      Source IDH51-65C68AE7EBEFA90FC131DEE1
      Title
      Amphotericin B lipid complex injection (Abelcet)
      Source IDH51-AA93C56DB61C6865198B332A
      Routes
      1. INTRAVENOUS
        Source IDH51-4BB4F979C30F9256FDF10A15
      Match confidence
      reviewed_archived_label
      Source IDH51-774B4857B44ECAE94B147AA5
      Field provenance
      Exact formulation
      Primary
      official_dailymed_archived_label_summary
      Source IDH51-571BF02A3A1E6F39D82FDA5E
      Reconstitution concentration
      Primary
      official_dailymed_archived_label_summary
      Source IDH51-C75D6849FF2D6B892DEC6C4C
      Maximum or recommended final concentration
      Primary
      official_dailymed_archived_label_summary
      Source IDH51-7DC9D212C1DDEA51065BC172
      Appropriate standardized containers
      Primary
      official_dailymed_archived_label_summary
      Source IDH51-CD8B8A75BD78EF97D32FA9F5
      Adult dosing range
      Primary
      official_dailymed_archived_label_summary
      Source IDH51-0BB7C61441407B4D12050CC7
      Pediatric dosing range
      Primary
      official_dailymed_archived_label_summary
      Source IDH51-C4CF55AEF7424D98F3930BC6
      Neonatal dosing range
      Primary
      official_dailymed_archived_label_summary
      Source IDH51-B5E9BF5576A6B5267CD2A8F1
      Infusion time
      Primary
      official_dailymed_archived_label_summary
      Source IDH51-2C4DABDD92C4995D6512809E
      Fluid restriction alternatives
      Primary
      official_dailymed_archived_label_summary
      Source IDH51-D1D8882A7163FC633E0A421B
      Current manufacturer labeling
      Primary
      official_dailymed_archived_label_summary
      Source IDH51-C94FC58AD7C9F5C69377F789
      Population applicability
      Adult
      Applicability
      supported_or_source_present
      Source IDH51-9D4C67D48C35B2FE994B805C
      Guide generation allowed
      false
      Source IDH51-48656EE0CB706D2703B3F42D
      Pediatric
      Applicability
      supported_or_source_present
      Source IDH51-4C0674C5277041B23DE7EA63
      Guide generation allowed
      false
      Source IDH51-0B10EFF60972A53FB1DA3B51
      Neonatal
      Applicability
      not_established_or_requires_separate_guidance
      Source IDH51-27438BFBDD5CD4134EABC4CA
      Guide generation allowed
      false
      Source IDH51-00B803499CB4ECB38365E93B
      Route presence
      Structured dilution
      false
      Source IDH51-43096ED84E98E2B5DCD858C2
      Iv push
      false
      Source IDH51-6C5E4782EAD242D415A6D2F5
      Continuous infusion
      true
      Source IDH51-847E25C731ADE5C700F29895
      Pediatric source
      true
      Source IDH51-692FC63755C74B55AED3F9F2
      Neonatal source
      true
      Source IDH51-D484101240D2D6F65F4FFD24
      Legacy reference
      Status
      not_available
      Source IDH51-20483F0583EFF0A0A2BC7754
      Label resolution
      Status
      reviewed_archived_official_label
      Source IDH51-C5F654FEDD852FAD9592118B
      Existing setids
      1. 5587db37-f21a-4a39-a319-e1077032ced9
        Source IDH51-7F18C8B1D640D2AC61073294
      Review date
      2026-08-30
      Source IDH51-CF969872D661050E5AAA3D90
      Source files
      1. catalog.json
        Source IDH51-242DD09AA732A4BD35AF395A
      2. dosing.json
        Source IDH51-9A85F7C9571C90D241370B5C
      3. legacy-map.json
        Source IDH51-A0BB4ACE598704020876C82F
      4. review-queue.json
        Source IDH51-624630441424E45E9D35CC42
      Clinical release note
      Archived official label summary. Do not infer current U.S. commercial availability.
      Source IDH51-3E8238F4A7661C877D619C4F
      Local label summary
      Available
      true
      Source IDH51-8A9D4540B351A04CAB080B96
      Status level
      archived
      Source IDH51-314017E629DC7B4685B068FA
      Title
      Amphotericin B lipid complex injection (Abelcet)
      Source IDH51-9D5631E0782A8379D6372FA5
      Historical statement IDs and source locations

      These IDs identify recovered source units. They are not evidence-qualified clinical claims.

      Historical IDOriginal source locationStatus
      H51-A7FB1A4E7E7C3F99809C25D8catalog.json
      /records/18/id
      Historical; current review incomplete
      H51-92CF55DCCBBDE95194AD41B8catalog.json
      /records/18/legacy_title
      Historical; current review incomplete
      H51-A8F876D24A7E2439DF6B8409catalog.json
      /records/18/generic_name
      Historical; current review incomplete
      H51-3B96CBBB60B7818E2A6B9829catalog.json
      /records/18/class
      Historical; current review incomplete
      H51-7ECB8B9D4F3BC65B90341C44catalog.json
      /records/18/subclass
      Historical; current review incomplete
      H51-F298361D1D933A1BA830A704catalog.json
      /records/18/summary
      Historical; current review incomplete
      H51-8A2011802254756741ACC57Ecatalog.json
      /records/18/warnings/0
      Historical; current review incomplete
      H51-2E6A75FF0E0129FA43B60885catalog.json
      /records/18/stability_notes/0
      Historical; current review incomplete
      H51-E8F570B625C34AC7DBD5FC27catalog.json
      /records/18/populations/0
      Historical; current review incomplete
      H51-82D82F4D054B6662F7E37103catalog.json
      /records/18/evidence_tier
      Historical; current review incomplete
      H51-21DCE240EACBDB25652CD0C5catalog.json
      /records/18/high_alert
      Historical; current review incomplete
      H51-AD90EE3195AA202AD810A881catalog.json
      /records/18/hazardous
      Historical; current review incomplete
      H51-10511BE5646C802F13AEF959catalog.json
      /records/18/status
      Historical; current review incomplete
      H51-924D01E2CAA4B9800B564CC8catalog.json
      /records/18/reviewed
      Historical; current review incomplete
      H51-6FA2D0BDC3960BCC57A81275catalog.json
      /records/18/version_added
      Historical; current review incomplete
      H51-C64411F1B653FA57D67D499Ecatalog.json
      /records/18/sources/0
      Historical; current review incomplete
      H51-D0F03061427545360F00DB73catalog.json
      /records/18/sources/0/label
      Historical; current review incomplete
      H51-E1268AFE337858AF4F6072B3catalog.json
      /records/18/sources/0/url
      Historical; current review incomplete
      H51-8F6B99AA92D0810646075F39catalog.json
      /records/18/sources/0/kind
      Historical; current review incomplete
      H51-54C140C32017397F1A5FFAB9catalog.json
      /records/18/clinical_release_verification/audit_version
      Historical; current review incomplete
      H51-2C8AFA59064D518FB000DBB7catalog.json
      /records/18/clinical_release_verification/audited_on
      Historical; current review incomplete
      H51-0E02DA1B0B662F91E25E5932catalog.json
      /records/18/clinical_release_verification/level
      Historical; current review incomplete
      H51-2DF99DD9DC3792BA2E4133FAcatalog.json
      /records/18/clinical_release_verification/release_gate
      Historical; current review incomplete
      H51-7C4AAFF9F0F365877E19C60Fcatalog.json
      /records/18/clinical_release_verification/exact_current_label_candidate
      Historical; current review incomplete
      H51-07392533497650D1FEE612CEcatalog.json
      /records/18/clinical_release_verification/selected_setid
      Historical; current review incomplete
      H51-71EFA860D7382726B9FA8620catalog.json
      /records/18/clinical_release_verification/selected_label_title
      Historical; current review incomplete
      H51-DBEE0C77E0EDD8F7CB959F7Acatalog.json
      /records/18/clinical_release_verification/numeric_support_ratio
      Historical; current review incomplete
      H51-EFBBE5D46BCE0D40B1F6AFECcatalog.json
      /records/18/clinical_release_verification/reference_url_count
      Historical; current review incomplete
      H51-ACA1643304109FDB0617E861catalog.json
      /records/18/clinical_release_verification/broken_reference_count
      Historical; current review incomplete
      H51-1E210F495164AC40ABB75926catalog.json
      /records/18/clinical_release_verification/point_of_use_confirmation_required
      Historical; current review incomplete
      H51-D3F58E3F19074A808E11413Ccatalog.json
      /records/18/clinical_release_verification/note
      Historical; current review incomplete
      H51-F22E56369FF9D19C49A0AD0Ecatalog.json
      /records/18/clinical_release_verification/dailymed_search_url
      Historical; current review incomplete
      H51-2ABCD5B81CE7B77CD5253DC3catalog.json
      /records/18/version_updated
      Historical; current review incomplete
      H51-36C7059C1CC88CAB18788E10dailymed-label-snapshots-v5.1.json
      /records/3/id
      Historical; current review incomplete
      H51-660FE994704DFA059782A09Ddailymed-label-snapshots-v5.1.json
      /records/3/catalog_name
      Historical; current review incomplete
      H51-61D6F7C0BCB55A36C469E4C7dailymed-label-snapshots-v5.1.json
      /records/3/selection_status
      Historical; current review incomplete
      H51-470506A5AEBDCE246A659EBBdailymed-label-snapshots-v5.1.json
      /records/3/confidence
      Historical; current review incomplete
      H51-58D717A9C68C3956EAC9B80Bdailymed-label-snapshots-v5.1.json
      /records/3/match_path
      Historical; current review incomplete
      H51-0448C0A33BF6AA547293D990dailymed-label-snapshots-v5.1.json
      /records/3/brand_name
      Historical; current review incomplete
      H51-79DB2FF48DC30868DF1917A3dailymed-label-snapshots-v5.1.json
      /records/3/label_title
      Historical; current review incomplete
      H51-F5036E0AABE78CD5540AD86Cdailymed-label-snapshots-v5.1.json
      /records/3/labeler
      Historical; current review incomplete
      H51-7C3020214D2E607CD185285Bdailymed-label-snapshots-v5.1.json
      /records/3/setid
      Historical; current review incomplete
      H51-A6C8E0443A4D7BF8E5316D9Cdailymed-label-snapshots-v5.1.json
      /records/3/official_label_url
      Historical; current review incomplete
      H51-489A1744006AEC16FC6EFA70dailymed-label-snapshots-v5.1.json
      /records/3/reviewed_on
      Historical; current review incomplete
      H51-90174E98ACA033969F39EBCAdailymed-label-snapshots-v5.1.json
      /records/3/route
      Historical; current review incomplete
      H51-EEA76F086E65BB2032FE951Fdailymed-label-snapshots-v5.1.json
      /records/3/dosage_form
      Historical; current review incomplete
      H51-9382DD1DBDBD9B8C1334ECF7dailymed-label-snapshots-v5.1.json
      /records/3/dosage_administration_summary/0
      Historical; current review incomplete
      H51-1791DAF86AA1389C92C78CF6dailymed-label-snapshots-v5.1.json
      /records/3/dosage_administration_summary/1
      Historical; current review incomplete
      H51-CEAAAFD78166F34B1DEE5824dailymed-label-snapshots-v5.1.json
      /records/3/dosage_administration_summary/2
      Historical; current review incomplete
      H51-313971DC5B7ADE709F8CD458dailymed-label-snapshots-v5.1.json
      /records/3/dosage_administration_summary/3
      Historical; current review incomplete
      H51-CA01410A822A265D4C506B08dailymed-label-snapshots-v5.1.json
      /records/3/dosage_administration_summary/4
      Historical; current review incomplete
      H51-CFCCF441CB3DF026955FFA92dailymed-label-snapshots-v5.1.json
      /records/3/dosage_administration_summary/5
      Historical; current review incomplete
      H51-0FA49A5271C1BAEFF1775CBFdailymed-label-snapshots-v5.1.json
      /records/3/dosage_forms_strengths/0
      Historical; current review incomplete
      H51-75A1EC4458EA803B99AE544Bdailymed-label-snapshots-v5.1.json
      /records/3/dosage_forms_strengths/1
      Historical; current review incomplete
      H51-275AF18A73DA1322333B0765dailymed-label-snapshots-v5.1.json
      /records/3/mechanism_summary
      Historical; current review incomplete
      H51-7BF06C49AC7965299FA8338Bdailymed-label-snapshots-v5.1.json
      /records/3/mechanism_source
      Historical; current review incomplete
      H51-371795E482F52C18FA20876Cdailymed-label-snapshots-v5.1.json
      /records/3/scope_note
      Historical; current review incomplete
      H51-BA8475592B9CE53FC1D566CFdailymed-label-snapshots-v5.1.json
      /records/3/source_sections/0
      Historical; current review incomplete
      H51-A56EA815A14BD04C06A40DE8dailymed-label-snapshots-v5.1.json
      /records/3/source_sections/1
      Historical; current review incomplete
      H51-202D5E53CD010D386570FA99dailymed-label-snapshots-v5.1.json
      /records/3/source_sections/2
      Historical; current review incomplete
      H51-CD26F57513702D05EDA2765Cdailymed-label-snapshots-v5.1.json
      /records/3/retrieval_method
      Historical; current review incomplete
      H51-227E3ACC81CD541B42FD54C3dailymed-label-snapshots-v5.1.json
      /records/3/label_status
      Historical; current review incomplete
      H51-ED7F68A86334C1347584B6B4dailymed-label-snapshots-v5.1.json
      /records/3/disclaimer
      Historical; current review incomplete
      H51-90B0768AB01DF3129F249DCBdosing.json
      /records/18/id
      Historical; current review incomplete
      H51-E63FEEAC5D81ED8D3EF92C78dosing.json
      /records/18/generic_name
      Historical; current review incomplete
      H51-E9FAC943136742538DE3CF9Adosing.json
      /records/18/coverage_status
      Historical; current review incomplete
      H51-7C53850F5D6A9D9A54F7CA77dosing.json
      /records/18/package_insert/query_name
      Historical; current review incomplete
      H51-67BB5A25C5B58326B0B54B73dosing.json
      /records/18/package_insert/preferred_setid
      Historical; current review incomplete
      H51-A402DE3B3D0F807ECB72F1ABdosing.json
      /records/18/package_insert/product_and_route_must_match
      Historical; current review incomplete
      H51-C99A2879AC5751D9F48FB4E0dosing.json
      /records/18/package_insert/live_current_label_enabled
      Historical; current review incomplete
      H51-00F8270F436E92E281CD30BFdosing.json
      /records/18/package_insert/source_priority
      Historical; current review incomplete
      H51-063246BF795D202C262106C5dosing.json
      /records/18/package_insert/direct_official_label_access_enabled
      Historical; current review incomplete
      H51-A2331F5A062F402245BD9ADBdosing.json
      /records/18/package_insert/outbound_server_request_required
      Historical; current review incomplete
      H51-9556CE018D0129933FE69B91dosing.json
      /records/18/package_insert/local_summary_status
      Historical; current review incomplete
      H51-BA288D116B89668079C12C6Ddosing.json
      /records/18/renal/classification
      Historical; current review incomplete
      H51-541A534939A90E4CBE233840dosing.json
      /records/18/renal/summary
      Historical; current review incomplete
      H51-3BEAFF7675A9268F076ADF30dosing.json
      /records/18/renal/method_note
      Historical; current review incomplete
      H51-BB4512AACAC33D1B36A7488Fdosing.json
      /records/18/professional_sources/0
      Historical; current review incomplete
      H51-F470DAF97BB2C59AAE7C8027dosing.json
      /records/18/professional_sources/0/label
      Historical; current review incomplete
      H51-AB8F569DD875F4BE29575673dosing.json
      /records/18/professional_sources/0/url
      Historical; current review incomplete
      H51-C813C01C303F2CE8ECCDD74Edosing.json
      /records/18/professional_sources/0/kind
      Historical; current review incomplete
      H51-F795337BE666F79CC50853BBdosing.json
      /records/18/professional_sources/1
      Historical; current review incomplete
      H51-F8D31534ABBB9D194D8D5A00dosing.json
      /records/18/professional_sources/1/label
      Historical; current review incomplete
      H51-554D6A9E626342DEC343E8EDdosing.json
      /records/18/professional_sources/1/url
      Historical; current review incomplete
      H51-A483C245D6C9DEC6E5EF2C75dosing.json
      /records/18/professional_sources/1/kind
      Historical; current review incomplete
      H51-0FF83EF5BE642D5FE121F928dosing.json
      /records/18/professional_sources/2
      Historical; current review incomplete
      H51-F29DF5FE91F574E3B9BC4F57dosing.json
      /records/18/professional_sources/2/label
      Historical; current review incomplete
      H51-4DF150CFD92D8FB64673B70Cdosing.json
      /records/18/professional_sources/2/url
      Historical; current review incomplete
      H51-3A9FAF53E89187D852EDB077dosing.json
      /records/18/professional_sources/2/kind
      Historical; current review incomplete
      H51-ABF029FD2D271514E5ECBC8Cdosing.json
      /records/18/professional_sources/3
      Historical; current review incomplete
      H51-9F236747570C431CBB2421C9dosing.json
      /records/18/professional_sources/3/label
      Historical; current review incomplete
      H51-72E559D39E403B81D08C58B8dosing.json
      /records/18/professional_sources/3/url
      Historical; current review incomplete
      H51-15D697BF8F688799DB68FCA3dosing.json
      /records/18/professional_sources/3/kind
      Historical; current review incomplete
      H51-C852F87A9B9EEDA168C2DE8Bdosing.json
      /records/18/clinical_review/locally_normalized
      Historical; current review incomplete
      H51-DFBDD2DDB0439F82A8B0D67Fdosing.json
      /records/18/clinical_review/reviewed
      Historical; current review incomplete
      H51-170AE8C618ECE976ED18C3BAdosing.json
      /records/18/clinical_review/status
      Historical; current review incomplete
      H51-6EC9156178F970379343490Adosing.json
      /records/18/clinical_release_verification/audit_version
      Historical; current review incomplete
      H51-CB8306F70376F58BF1101B39dosing.json
      /records/18/clinical_release_verification/audited_on
      Historical; current review incomplete
      H51-3ECF328D9587B1AC79E9C75Adosing.json
      /records/18/clinical_release_verification/level
      Historical; current review incomplete
      H51-BFD39781747ACC8425308773dosing.json
      /records/18/clinical_release_verification/release_gate
      Historical; current review incomplete
      H51-EAA8D51BA11D6CD788C561E5dosing.json
      /records/18/clinical_release_verification/exact_current_label_candidate
      Historical; current review incomplete
      H51-121C2B375CF62DE2926CD092dosing.json
      /records/18/clinical_release_verification/selected_setid
      Historical; current review incomplete
      H51-0B32AD068736F4AC9ECBA045dosing.json
      /records/18/clinical_release_verification/selected_label_title
      Historical; current review incomplete
      H51-89432B8AB49310F85467E63Bdosing.json
      /records/18/clinical_release_verification/numeric_support_ratio
      Historical; current review incomplete
      H51-F7C34D40C84F3DF25ED287C3dosing.json
      /records/18/clinical_release_verification/reference_url_count
      Historical; current review incomplete
      H51-FED687ABAD70FDD259E229BEdosing.json
      /records/18/clinical_release_verification/broken_reference_count
      Historical; current review incomplete
      H51-986936927E7B0515AC189528dosing.json
      /records/18/clinical_release_verification/point_of_use_confirmation_required
      Historical; current review incomplete
      H51-02AA55024F1D33B6CA5D1762dosing.json
      /records/18/clinical_release_verification/note
      Historical; current review incomplete
      H51-84A179D07C05629730A877FEdosing.json
      /records/18/clinical_release_verification/dailymed_search_url
      Historical; current review incomplete
      H51-EC12E0680A64DB8540BDCAC9first-look-v5.1.json
      /records/18/id
      Historical; current review incomplete
      H51-F87102A775E7537EF87C9CF2first-look-v5.1.json
      /records/18/generic_name
      Historical; current review incomplete
      H51-F77D1FED80912ABA84C56459first-look-v5.1.json
      /records/18/class
      Historical; current review incomplete
      H51-9919CC0EA6063D1DAE087B3Ffirst-look-v5.1.json
      /records/18/subclass
      Historical; current review incomplete
      H51-6857F1B01FEA9C9CEA158A72first-look-v5.1.json
      /records/18/primary_uses/0
      Historical; current review incomplete
      H51-CE9F8A74E007CD5AF805CA2Dfirst-look-v5.1.json
      /records/18/mechanism
      Historical; current review incomplete
      H51-0CC0CA1C5F1B6BE23DB83351first-look-v5.1.json
      /records/18/mechanism_level
      Historical; current review incomplete
      H51-9847926636C3185EA09D4323first-look-v5.1.json
      /records/18/basic_dosing_orientation
      Historical; current review incomplete
      H51-D97CA7E125DFB6319EF3FB34first-look-v5.1.json
      /records/18/administration_orientation
      Historical; current review incomplete
      H51-8E4DF0E688EB36684E6A0BF5first-look-v5.1.json
      /records/18/renal_and_population_orientation
      Historical; current review incomplete
      H51-EA2F8ACB7000E281FFD4B611first-look-v5.1.json
      /records/18/key_safety_orientation/0
      Historical; current review incomplete
      H51-CFBA4FD877830AD2C31B7C43first-look-v5.1.json
      /records/18/key_safety_orientation/1
      Historical; current review incomplete
      H51-83A235DA6F1B55D1CCD1E06Bfirst-look-v5.1.json
      /records/18/coverage_path
      Historical; current review incomplete
      H51-DBB217CD959407724F005DDBfirst-look-v5.1.json
      /records/18/coverage_path_label
      Historical; current review incomplete
      H51-9A4D85364610E6AC52F637B9first-look-v5.1.json
      /records/18/official_label_url
      Historical; current review incomplete
      H51-6111A58C3594140A080CA215first-look-v5.1.json
      /records/18/legacy_title
      Historical; current review incomplete
      H51-E030FCB780DDE2766ADA0144first-look-v5.1.json
      /records/18/review_note
      Historical; current review incomplete
      H51-35992005BFC3BB6CD69FC247first-look-v5.1.json
      /records/18/search_text
      Historical; current review incomplete
      H51-B20466314D1D9390E32B44B7first-look-v5.1.json
      /records/18/official_search_url
      Historical; current review incomplete
      H51-2A697EDC5813C054384B70E2first-look-v5.1.json
      /records/18/official_access_mode
      Historical; current review incomplete
      H51-FA66CF6357944B58262F6C80first-look-v5.1.json
      /records/18/official_access_url
      Historical; current review incomplete
      H51-3E6FD21A299FDEF61C9CEB54first-look-v5.1.json
      /records/18/official_search_query
      Historical; current review incomplete
      H51-CF2EB4B0508B9BE1E00D0C35first-look-v5.1.json
      /records/18/official_access_reason
      Historical; current review incomplete
      H51-2D87ED9E25C969EB38FC78DBfirst-look-v5.1.json
      /records/18/label_snapshot_available
      Historical; current review incomplete
      H51-380473B09C3B8F7B8E7232E0first-look-v5.1.json
      /records/18/label_snapshot_setid
      Historical; current review incomplete
      H51-90248A6292A9AD095EA243D7local-label-summaries-v3.8.json
      /summaries/3/id
      Historical; current review incomplete
      H51-5CA2B43CB1C41358095CF7D5local-label-summaries-v3.8.json
      /summaries/3/match_names/0
      Historical; current review incomplete
      H51-58CEA27E588461D820CB9A0Flocal-label-summaries-v3.8.json
      /summaries/3/match_names/1
      Historical; current review incomplete
      H51-3BC888FB031D391F5CAB4677local-label-summaries-v3.8.json
      /summaries/3/label_title
      Historical; current review incomplete
      H51-BB6F56BD85BF29A8873E7943local-label-summaries-v3.8.json
      /summaries/3/brand_names/0
      Historical; current review incomplete
      H51-12677563805B9A097FB88260local-label-summaries-v3.8.json
      /summaries/3/formulation
      Historical; current review incomplete
      H51-064A1D577873392903450EA6local-label-summaries-v3.8.json
      /summaries/3/reconstitution
      Historical; current review incomplete
      H51-733583780B706FE7C18B7D7Elocal-label-summaries-v3.8.json
      /summaries/3/stock_concentration
      Historical; current review incomplete
      H51-7001AA978E7CB27B30015602local-label-summaries-v3.8.json
      /summaries/3/diluents
      Historical; current review incomplete
      H51-399A5734521A2E98875C6DE4local-label-summaries-v3.8.json
      /summaries/3/final_concentration
      Historical; current review incomplete
      H51-0D1BC155561766A66CC80DC6local-label-summaries-v3.8.json
      /summaries/3/containers
      Historical; current review incomplete
      H51-69AD63C46B2E1007B4086E47local-label-summaries-v3.8.json
      /summaries/3/infusion_time
      Historical; current review incomplete
      H51-04FD3C1E2934902703FF2C3Flocal-label-summaries-v3.8.json
      /summaries/3/fluid_restriction
      Historical; current review incomplete
      H51-52600D3F3B6D1673325B337Blocal-label-summaries-v3.8.json
      /summaries/3/stability
      Historical; current review incomplete
      H51-BA22986FFAF1E62F0A4CE723local-label-summaries-v3.8.json
      /summaries/3/line_filter
      Historical; current review incomplete
      H51-FB9B19480AE04DFADEB387E9local-label-summaries-v3.8.json
      /summaries/3/adult_applicability
      Historical; current review incomplete
      H51-46BF988569EE626256CE46F1local-label-summaries-v3.8.json
      /summaries/3/pediatric_applicability
      Historical; current review incomplete
      H51-CBF4CBA0023B3E2BCF7C8A2Elocal-label-summaries-v3.8.json
      /summaries/3/neonatal_applicability
      Historical; current review incomplete
      H51-62FB863182723CF6C81D34AFlocal-label-summaries-v3.8.json
      /summaries/3/renal_dialysis
      Historical; current review incomplete
      H51-85DFD2094142724598601013local-label-summaries-v3.8.json
      /summaries/3/key_warnings
      Historical; current review incomplete
      H51-9999F97D41BAC263F8055E36local-label-summaries-v3.8.json
      /summaries/3/catalog_id
      Historical; current review incomplete
      H51-BCE18EE1FEF1D717F07E7038local-label-summaries-v3.8.json
      /summaries/3/catalog_name
      Historical; current review incomplete
      H51-FDE4B5FDA5DE0553E872040Dlocal-label-summaries-v3.8.json
      /summaries/3/review_date
      Historical; current review incomplete
      H51-3A2D514FD790F9181F335C3Clocal-label-summaries-v3.8.json
      /summaries/3/source_type
      Historical; current review incomplete
      H51-C861DAECC03A91C8F0F7030Flocal-label-summaries-v3.8.json
      /summaries/3/official_link_type
      Historical; current review incomplete
      H51-97D56550D4D0D67D812B041Blocal-label-summaries-v3.8.json
      /summaries/3/official_label_url
      Historical; current review incomplete
      H51-E22A3B8AFEF5EAC6E3BF47C8local-label-summaries-v3.8.json
      /summaries/3/official_search_url
      Historical; current review incomplete
      H51-9549858FF025276B52D34355local-label-summaries-v3.8.json
      /summaries/3/search_text
      Historical; current review incomplete
      H51-859C06F2F9323385339E3361local-label-summaries-v3.8.json
      /summaries/3/label_status
      Historical; current review incomplete
      H51-D80B1A520EB8A6BA425C61EFlocal-label-summaries-v3.8.json
      /summaries/3/label_status_level
      Historical; current review incomplete
      H51-28C966B299ECED4751EE739Epreparation-assessments-v3.8.json
      /18/id
      Historical; current review incomplete
      H51-F6E957399907A7684A73DFDBpreparation-assessments-v3.8.json
      /18/name
      Historical; current review incomplete
      H51-1AA6D47F6E2D5D4E3634CAD1preparation-assessments-v3.8.json
      /18/brands
      Historical; current review incomplete
      H51-DF30314E33922F5701AE7B5Fpreparation-assessments-v3.8.json
      /18/therapeutic_class
      Historical; current review incomplete
      H51-98AAE8291BF8854E3A35CDF7preparation-assessments-v3.8.json
      /18/review_version
      Historical; current review incomplete
      H51-0C630DCBDBB58EA83384D948preparation-assessments-v3.8.json
      /18/review_date
      Historical; current review incomplete
      H51-800E0DF2777E30356D93EAEFpreparation-assessments-v3.8.json
      /18/release_status
      Historical; current review incomplete
      H51-E5E2C967DC4B8940AB0D69DEpreparation-assessments-v3.8.json
      /18/market_status/status
      Historical; current review incomplete
      H51-5E7C23B2D62BFBF406FD0442preparation-assessments-v3.8.json
      /18/market_status/basis
      Historical; current review incomplete
      H51-78E5B557E28CF6A2657F2B9Apreparation-assessments-v3.8.json
      /18/ten_point_assessment/exact_formulation
      Historical; current review incomplete
      H51-18353ADAEE276C2A4E2A26A7preparation-assessments-v3.8.json
      /18/ten_point_assessment/reconstitution_concentration
      Historical; current review incomplete
      H51-B410DAF3B6F8E46DF82BEE97preparation-assessments-v3.8.json
      /18/ten_point_assessment/maximum_or_recommended_final_concentration
      Historical; current review incomplete
      H51-D0D591D5F1878AE720F66AD8preparation-assessments-v3.8.json
      /18/ten_point_assessment/appropriate_standardized_containers
      Historical; current review incomplete
      H51-244168F7ABAC1877C9E604D8preparation-assessments-v3.8.json
      /18/ten_point_assessment/adult_dosing_range
      Historical; current review incomplete
      H51-447D68890C90A05B7F6A3D42preparation-assessments-v3.8.json
      /18/ten_point_assessment/pediatric_dosing_range
      Historical; current review incomplete
      H51-329499090578E391383E8CDApreparation-assessments-v3.8.json
      /18/ten_point_assessment/neonatal_dosing_range
      Historical; current review incomplete
      H51-9F1AA15BBB13BD6BD55D082Dpreparation-assessments-v3.8.json
      /18/ten_point_assessment/infusion_time
      Historical; current review incomplete
      H51-4686AC7D68EFBD5DBF457953preparation-assessments-v3.8.json
      /18/ten_point_assessment/fluid_restriction_alternatives
      Historical; current review incomplete
      H51-65C68AE7EBEFA90FC131DEE1preparation-assessments-v3.8.json
      /18/ten_point_assessment/current_manufacturer_labeling/setid
      Historical; current review incomplete
      H51-AA93C56DB61C6865198B332Apreparation-assessments-v3.8.json
      /18/ten_point_assessment/current_manufacturer_labeling/title
      Historical; current review incomplete
      H51-5A65170093C2171828474562preparation-assessments-v3.8.json
      /18/ten_point_assessment/current_manufacturer_labeling/published_date
      Historical; current review incomplete
      H51-5EC275AC254441B51AD369C4preparation-assessments-v3.8.json
      /18/ten_point_assessment/current_manufacturer_labeling/manufacturer
      Historical; current review incomplete
      H51-4BB4F979C30F9256FDF10A15preparation-assessments-v3.8.json
      /18/ten_point_assessment/current_manufacturer_labeling/routes/0
      Historical; current review incomplete
      H51-774B4857B44ECAE94B147AA5preparation-assessments-v3.8.json
      /18/ten_point_assessment/current_manufacturer_labeling/match_confidence
      Historical; current review incomplete
      H51-47A964FF7189EC8EDA07B95Cpreparation-assessments-v3.8.json
      /18/ten_point_assessment/current_manufacturer_labeling/url
      Historical; current review incomplete
      H51-571BF02A3A1E6F39D82FDA5Epreparation-assessments-v3.8.json
      /18/field_provenance/exact_formulation/primary
      Historical; current review incomplete
      H51-C75D6849FF2D6B892DEC6C4Cpreparation-assessments-v3.8.json
      /18/field_provenance/reconstitution_concentration/primary
      Historical; current review incomplete
      H51-7DC9D212C1DDEA51065BC172preparation-assessments-v3.8.json
      /18/field_provenance/maximum_or_recommended_final_concentration/primary
      Historical; current review incomplete
      H51-CD8B8A75BD78EF97D32FA9F5preparation-assessments-v3.8.json
      /18/field_provenance/appropriate_standardized_containers/primary
      Historical; current review incomplete
      H51-0BB7C61441407B4D12050CC7preparation-assessments-v3.8.json
      /18/field_provenance/adult_dosing_range/primary
      Historical; current review incomplete
      H51-C4CF55AEF7424D98F3930BC6preparation-assessments-v3.8.json
      /18/field_provenance/pediatric_dosing_range/primary
      Historical; current review incomplete
      H51-B5E9BF5576A6B5267CD2A8F1preparation-assessments-v3.8.json
      /18/field_provenance/neonatal_dosing_range/primary
      Historical; current review incomplete
      H51-2C4DABDD92C4995D6512809Epreparation-assessments-v3.8.json
      /18/field_provenance/infusion_time/primary
      Historical; current review incomplete
      H51-D1D8882A7163FC633E0A421Bpreparation-assessments-v3.8.json
      /18/field_provenance/fluid_restriction_alternatives/primary
      Historical; current review incomplete
      H51-C94FC58AD7C9F5C69377F789preparation-assessments-v3.8.json
      /18/field_provenance/current_manufacturer_labeling/primary
      Historical; current review incomplete
      H51-9D4C67D48C35B2FE994B805Cpreparation-assessments-v3.8.json
      /18/population_applicability/adult/applicability
      Historical; current review incomplete
      H51-48656EE0CB706D2703B3F42Dpreparation-assessments-v3.8.json
      /18/population_applicability/adult/guide_generation_allowed
      Historical; current review incomplete
      H51-4C0674C5277041B23DE7EA63preparation-assessments-v3.8.json
      /18/population_applicability/pediatric/applicability
      Historical; current review incomplete
      H51-0B10EFF60972A53FB1DA3B51preparation-assessments-v3.8.json
      /18/population_applicability/pediatric/guide_generation_allowed
      Historical; current review incomplete
      H51-27438BFBDD5CD4134EABC4CApreparation-assessments-v3.8.json
      /18/population_applicability/neonatal/applicability
      Historical; current review incomplete
      H51-00B803499CB4ECB38365E93Bpreparation-assessments-v3.8.json
      /18/population_applicability/neonatal/guide_generation_allowed
      Historical; current review incomplete
      H51-43096ED84E98E2B5DCD858C2preparation-assessments-v3.8.json
      /18/route_presence/structured_dilution
      Historical; current review incomplete
      H51-6C5E4782EAD242D415A6D2F5preparation-assessments-v3.8.json
      /18/route_presence/iv_push
      Historical; current review incomplete
      H51-847E25C731ADE5C700F29895preparation-assessments-v3.8.json
      /18/route_presence/continuous_infusion
      Historical; current review incomplete
      H51-692FC63755C74B55AED3F9F2preparation-assessments-v3.8.json
      /18/route_presence/pediatric_source
      Historical; current review incomplete
      H51-D484101240D2D6F65F4FFD24preparation-assessments-v3.8.json
      /18/route_presence/neonatal_source
      Historical; current review incomplete
      H51-20483F0583EFF0A0A2BC7754preparation-assessments-v3.8.json
      /18/legacy_reference/status
      Historical; current review incomplete
      H51-C5F654FEDD852FAD9592118Bpreparation-assessments-v3.8.json
      /18/label_resolution/status
      Historical; current review incomplete
      H51-7F18C8B1D640D2AC61073294preparation-assessments-v3.8.json
      /18/label_resolution/existing_setids/0
      Historical; current review incomplete
      H51-7EBF9B38D3C93B2892B70EBFpreparation-assessments-v3.8.json
      /18/label_resolution/official_url
      Historical; current review incomplete
      H51-CF969872D661050E5AAA3D90preparation-assessments-v3.8.json
      /18/label_resolution/review_date
      Historical; current review incomplete
      H51-242DD09AA732A4BD35AF395Apreparation-assessments-v3.8.json
      /18/source_files/0
      Historical; current review incomplete
      H51-9A85F7C9571C90D241370B5Cpreparation-assessments-v3.8.json
      /18/source_files/1
      Historical; current review incomplete
      H51-A0BB4ACE598704020876C82Fpreparation-assessments-v3.8.json
      /18/source_files/2
      Historical; current review incomplete
      H51-624630441424E45E9D35CC42preparation-assessments-v3.8.json
      /18/source_files/3
      Historical; current review incomplete
      H51-3E8238F4A7661C877D619C4Fpreparation-assessments-v3.8.json
      /18/clinical_release_note
      Historical; current review incomplete
      H51-8A9D4540B351A04CAB080B96preparation-assessments-v3.8.json
      /18/local_label_summary/available
      Historical; current review incomplete
      H51-314017E629DC7B4685B068FApreparation-assessments-v3.8.json
      /18/local_label_summary/status_level
      Historical; current review incomplete
      H51-9D5631E0782A8379D6372FA5preparation-assessments-v3.8.json
      /18/local_label_summary/title
      Historical; current review incomplete
      H51-A797162BD70A08724F150EF2preparation-assessments-v3.8.json
      /18/local_label_summary/official_url
      Historical; current review incomplete